Status:
COMPLETED
Behavioural Economics-based Incentives in Adults With Type 2 Diabetes Pilot Study
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
University Grants Committee, Hong Kong
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
30-70 years
Phase:
NA
Brief Summary
A feasibility pilot study of a randomised control trial of adults newly diagnosed with type 2 diabetes to compare the effectiveness of financial and social incentives on healthy lifestyle behaviour.
Detailed Description
This is a pilot study of testing the feasibility of the interventions being implemented in our main trial in local settings. Adults newly diagnosed with type 2 diabetes without receiving any anti-diab...
Eligibility Criteria
Inclusion
- Chinese adults aged 30-70 years
- Capable of providing informed consent
- Resident in Hong Kong
- Able to communicate in English or Chinese
- Newly diagnosed with type 2 diabetes within a year according to World Health Organization guidelines: HbA1c ≥ 48 mmol/mol (≥ 6.5%); fasting plasma glucose ≥ 7.0 mmol/l (≥ 126 mg/dl); oral glucose tolerance test (OGTT) ≥ 11.1 mmol/l (200 mg/dl) with symptoms, or on two separate occasions if asymptomatic
- HbA1c ≤ 7.5%
- Not taking any medication for glycaemic control
- Willing to take blood tests
- Access to a smart phone to track physical activity
- Physically mobile for duration of the trial
Exclusion
- Already participating in another intervention study
- Any health condition prohibiting them from completing the 9-month trial, such as history of eating disorder, cancer, serious illness, breastfeeding
- Medical conditions that can affect HbA1c measurements including anaemia, haemoglobinopathies, haemodialysis, iron/B12 deficiency or supplements, chronic liver diseases, splenectomy, rheumatoid arthritis, use of anti-retroviral drugs, ribavirin, or aspirin
- Intend to receive medication for glycaemic control in the next 6 months
- Intend to seek private medical treatment for diabetes in the next 6 months
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2021
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04443842
Start Date
November 1 2020
End Date
December 7 2021
Last Update
May 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong
Hong Kong, Hong Kong